LEP and breast cancer: Eicosatetraenoic acid (EPA) is an anti-inflammatory n-3 polyunsaturated fatty acid, which reduces CAA-related inflammatory factors, such as IL-6, leptin, and PGE2, and reduces inflammation, glycolysis, and the motility of BC cells.